Publications

Probity Medical Research has compiled journals, articles and presentations for your personal review. Please use the search features below to find an article.

 

If you would like to request an article for personal review please complete the registration form. These publications are for personal use only and cannot be distributed. 

Register

 

Already granted access to an article?  

Login

 

If you cannot find the article you are looking for please contact Probity Medical Research. 

Journals, Articles and Presentations

Found 47 matches.
Page:
4
Refine your search to narrow the results.

Oral apremilast in the treatment of active psoriatic arthritis: Results of a multicenter, randomized, double-blind, placebo-controlled study

Arthritis & Rheumatism 2012 Oct;64(10):3156-67. doi: 10.1002/art.34627.

Journal
Arthritis & Rheumatism
PubMed ID
22806399
Condition
Psoriatic Arthritis
Author
Georg Schett, Jurgen Wollenhaupt, Kim Papp, Rik Joos, Jude F. Rodrigues, Adele R. Vessey, ChiaChi Hu, Randall Stevens, Kurt L. de Vlam
Year
2012
Register & Request Access

Secukinumab effectively treats moderate-to-severe psoriasis with a slow return of symptoms after cessation of therapy: Results of a dose finding study

Presented at the 21st European Academy of Dermatology and Venereology, Prague, Czech Republic, September 27-30, 2012.

Condition
Psoriasis
Author
R.G. Langley, D.R. Baker, P. Rich, K. Papp, A. Guettner, C. Papavassilis
Year
2012
Register & Request Access

The Efficacy of Apremilast Is Consistent Across Subgroups of Subjects With Moderate to Severe Plaque Psoriasis: Results From a Phase 2b Randomized, Controlled Study

Presented at the 28th Annual Dermatology Update, Vancouver, British Columbia, October 17-21 2012.

Condition
Psoriasis
Author
Kim Papp, Lorne Albrecht, Ronald Vender, Yves Poulin, ChiaChi Hu, Robert M. Day
Year
2012
Register & Request Access

Managing cardiovascular risk in patients with chronic inflammatory diseases

Clinical Rheumatology. 2012 Apr;31(4):585-94. Epub 2012 Jan 14.

Journal
Clinical Rheumatology (Clin Rheumatol)
PubMed ID
22246418
Condition
Inflammatory diseases, psoriasis
Author
Haraoui B, Liu PP, Papp KA
Year
2012
Register & Request Access

Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study

Journal of the European Academy of Dermatology and Venereology 2012 Oct 3. [Epub ahead of print]

Journal
Journal of the European Academy of Dermatology and Venereology (JEADV)
PubMed ID
23030767
Condition
Psoriasis
Author
K.A. Papp, R. Kaufmann, D. Thaci, C. Hu, D. Sutherland, P. Rohane
Year
2012
Register & Request Access

Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis

Journal of the European Academy of Dermatology and Venereology 2012 Nov 16. doi: 10.1111/j.1468-3083.2012.04705.x. [Epub ahead of print]

Journal
Journal of the European Academy of Dermatology and Venereology (JEADV)
PubMed ID
23157612
Condition
Psoriasis
Author
R.G. Langley, K. Papp, A.B. Gottlieb, G.G. Krueger, K.B. Gordon, D. Williams, J. Valdes, C. Setze, B. Strober
Year
2012
Register & Request Access

Psoriasis What it is and What can be done about it

Presented to Kitchener-Waterloo Pharmacists, Kitchener, Ontario, November 26, 2012.

Condition
Psoriasis
Author
K. Alexander Papp
Year
2012
Register & Request Access

Efectos de Tofacitinib en subpoblaciones linfocitarias y carga viral de CMV y EBV en pacientes con psoriasis en placa

Presented at SOLAPSO 1st Latin American Congress of Psoriasis, Buenos Aires, Argentina, 29 November - 2 December, 2012

Condition
Psoriasis
Author
Valenzuela F, Papp K, Pariser D, Tyring S, Wolk R, Buonanno M, Wang J, Valdez H
Year
2012
Register & Request Access

Psoriasis Pipeline - SOLAPSO 2012

Presented at SOLAPSO 1st Latin American Congress of Psoriasis, Buenos Aires, Argentina, 29 November - 2 December, 2012

Condition
Psoriasis
Author
K. Alexander Papp
Year
2012
Register & Request Access

Are Psoriasis Therapies Safe?

Presented at SOLAPSO 1st Latin American Congress of Psoriasis, Buenos Aires, Argentina, 29 November - 2 December, 2012

Condition
Psoriasis
Author
K.A. Papp
Year
2012
Register & Request Access
Page:
4

Copyright 2014 Probity Medical Research Inc. All Rights Reserved.

Login